These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 2868149

  • 1. Prognostic value of thyroid stimulating antibodies and TSH-binding inhibiting immunoglobulins in the follow-up of Graves' disease.
    Hörmann R, Saller B, Müller R, Mann K.
    Klin Wochenschr; 1985 Dec 16; 63(24):1247-52. PubMed ID: 2868149
    [Abstract] [Full Text] [Related]

  • 2. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
    Takasu N, Oshiro C, Akamine H, Komiya I, Nagata A, Sato Y, Yoshimura H, Ito K.
    J Endocrinol Invest; 1997 Sep 16; 20(8):452-61. PubMed ID: 9364248
    [Abstract] [Full Text] [Related]

  • 3. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
    Maugendre D, Massart C.
    Clin Endocrinol (Oxf); 2001 Jan 16; 54(1):89-96. PubMed ID: 11167931
    [Abstract] [Full Text] [Related]

  • 4. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
    Takasu N, Yamashiro K, Komiya I, Ochi Y, Sato Y, Nagata A.
    Thyroid; 2000 Oct 16; 10(10):891-6. PubMed ID: 11081255
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
    Tamaki H, Amino N, Iwatani Y, Tachi J, Kimura M, Mitsuda N, Ichihara K, Tanizawa O, Miyai K.
    Clin Endocrinol (Oxf); 1989 May 16; 30(5):493-503. PubMed ID: 2575017
    [Abstract] [Full Text] [Related]

  • 6. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K.
    J Clin Endocrinol Metab; 1987 Aug 16; 65(2):324-30. PubMed ID: 2885336
    [Abstract] [Full Text] [Related]

  • 7. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T.
    Thyroid; 1999 Oct 16; 9(10):979-88. PubMed ID: 10560951
    [Abstract] [Full Text] [Related]

  • 8. A study of untreated Graves' patients with undetectable TSH binding inhibitor immunoglobulins and the effect of anti-thyroid drugs.
    Kawai K, Tamai H, Matsubayashi S, Mukuta T, Morita T, Kubo C, Kuma K.
    Clin Endocrinol (Oxf); 1995 Nov 16; 43(5):551-6. PubMed ID: 8548939
    [Abstract] [Full Text] [Related]

  • 9. [Clinical studies on abnormal thyroid stimulators in patients with Graves' disease. II. Clinical significance of measuring TSAb and TBII in patients with euthyroid Graves' disease and patients with hyperthyroid Graves' disease during antithyroid drug treatment].
    Uno C, Nishikawa M.
    Nihon Naibunpi Gakkai Zasshi; 1988 Mar 20; 64(3):206-15. PubMed ID: 2456230
    [Abstract] [Full Text] [Related]

  • 10. The relationships between serum T3 index, thyroid volume, and thyroid stimulating, TSH receptor binding and thyroid growth stimulating antibodies in untreated Graves' disease.
    Bliddal H, Hegedüs L, Hansen JM, Bech K, van der Gaag R, Drexhage HA.
    Clin Endocrinol (Oxf); 1987 Jul 20; 27(1):75-84. PubMed ID: 2888551
    [Abstract] [Full Text] [Related]

  • 11. Thyroid-stimulating antibodies in patients with long-term remission of Graves' hyperthyroidism.
    Hörmann R, Hobelsberger A, Saller B, Mann K.
    Klin Wochenschr; 1986 Oct 31; 64(21):1097-100. PubMed ID: 2879958
    [Abstract] [Full Text] [Related]

  • 12. The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment.
    Bliddal H, Bech K, Siersbaek-Nielsen K, Friis T.
    J Endocrinol Invest; 1983 Aug 31; 6(4):259-62. PubMed ID: 6139399
    [Abstract] [Full Text] [Related]

  • 13. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W, Man N, Li YS, Shan ZY, Teng WP.
    Zhonghua Nei Ke Za Zhi; 2006 Feb 31; 45(2):95-9. PubMed ID: 16624113
    [Abstract] [Full Text] [Related]

  • 14. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY, Hamada N, Inoue Y, Abe Y, Ito K, Ito K.
    Thyroid; 2000 Sep 31; 10(9):809-13. PubMed ID: 11041459
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves' disease.
    Kasagi K, Hatabu H, Tokuda Y, Iida Y, Endo K, Konishi J.
    Clin Endocrinol (Oxf); 1988 Oct 31; 29(4):357-66. PubMed ID: 2908031
    [Abstract] [Full Text] [Related]

  • 17. Paired determination of thyroid-stimulating and TSH-binding inhibitory activities in patients with Graves' disease during antithyroid drug treatment.
    Kasagi K, Iida Y, Konishi J, Misaki T, Arai K, Endo K, Torizuka K, Kuma K.
    Acta Endocrinol (Copenh); 1986 Apr 31; 111(4):474-80. PubMed ID: 2422860
    [Abstract] [Full Text] [Related]

  • 18. Prediction of the course of Graves' disease after medical antithyroid treatment.
    Eshøj O, Kvetny J, Mogensen EF, Bech K, Bliddal H.
    Acta Med Scand; 1985 Apr 31; 217(2):225-8. PubMed ID: 2859737
    [Abstract] [Full Text] [Related]

  • 19. [Clinical relevance of the determination of TSH-binding inhibitory immunoglobulins (TBII) in patients with immunogenic hyperthyroidism in methimazole therapy].
    Heberling HJ, Bierwolf B, Kuhlmann E, Klugmann T, Dietel P, Fischer S.
    Dtsch Z Verdau Stoffwechselkr; 1987 Apr 31; 47(6):331-6. PubMed ID: 2896115
    [Abstract] [Full Text] [Related]

  • 20. Blocking-type anti-TSH receptor antibodies and relation to responsiveness to antithyroid drug therapy and remission in Graves' disease.
    Tada H, Mizuta I, Takano T, Tatsumi KI, Izumi Y, Hidaka Y, Amino N.
    Clin Endocrinol (Oxf); 2003 Apr 31; 58(4):403-8. PubMed ID: 12641621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.